AAAAAA
Results: 1-25/54
Authors:
Bralet, J
Schwartz, JC
Citation: J. Bralet et Jc. Schwartz, Vasopeptidase inhibitors: an emerging class of cardiovascular drugs, TRENDS PHAR, 22(3), 2001, pp. 106-109
Authors:
Stark, H
Krause, M
Rouleau, A
Garbarg, M
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Enzyme-catalyzed prodrug approaches for the histamine H-3-receptor agonist(R)-alpha-methylhistamine, BIO MED CH, 9(1), 2001, pp. 191-198
Authors:
Stark, H
Sippl, W
Ligneau, X
Arrang, JM
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Different antagonist binding properties of human and rat histamine H-3 receptors, BIOORG MED, 11(7), 2001, pp. 951-954
Authors:
Tardivel-Lacombe, J
Morisset, S
Gbahou, F
Schwartz, JC
Arrang, JM
Citation: J. Tardivel-lacombe et al., Chromosomal mapping and organization of the human histamine H-3 receptor gene, NEUROREPORT, 12(2), 2001, pp. 321-324
Authors:
Beardsley, PM
Sokoloff, P
Balster, RL
Schwartz, JC
Citation: Pm. Beardsley et al., The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered, BEHAV PHARM, 12(1), 2001, pp. 1-11
Authors:
Meier, G
Apelt, J
Reichert, U
Grassmann, S
Ligneau, X
Elz, S
Leurquin, F
Ganellin, CR
Schwartz, JC
Schunack, W
Stark, H
Citation: G. Meier et al., Influence of imidazole replacement in different structural classes of histamine H-3-receptor antagonists, EUR J PH SC, 13(3), 2001, pp. 249-259
Authors:
Heron, A
Rouleau, A
Cochois, V
Pillot, C
Schwartz, JC
Arrang, JM
Citation: A. Heron et al., Expression analysis of the histamine H-3 receptor in developing rat tissues, MECH DEVEL, 105(1-2), 2001, pp. 167-173
Authors:
Schwartz, JC
Morisset, S
Rouleau, A
Tardivel-Lacombe, J
Gbahou, F
Ligneau, X
Heron, A
Sasse, A
Stark, H
Schunack, W
Ganellin, RC
Arrang, JM
Citation: Jc. Schwartz et al., Application of genomics to drug design: the example of the histamine H-3 receptor, EUR NEUROPS, 11(6), 2001, pp. 441-448
Authors:
Sasse, A
Ligneau, X
Sadek, B
Elz, S
Pertz, HH
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands, ARCH PHARM, 334(2), 2001, pp. 45-52
Authors:
Monteil, T
Danvy, D
Plaquevent, JC
Duhamel, L
Duhamel, P
Gros, C
Schwartz, JC
Lecomte, JM
Citation: T. Monteil et al., New asymmetric synthesis of dexecadotril and ecadotril starting from a single precursor, SYN COMMUN, 31(2), 2001, pp. 211-218
Authors:
Guillin, O
Diaz, J
Carroll, P
Griffon, N
Schwartz, JC
Sokoloff, P
Citation: O. Guillin et al., BDNF controls dopamine D-3 receptor expression and triggers behavioural sensitization, NATURE, 411(6833), 2001, pp. 86-89
Authors:
Morisset, S
Sasse, A
Gbahou, F
Heron, A
Ligneau, X
Tardivel-Lacombe, J
Schwartz, JC
Arrang, JM
Citation: S. Morisset et al., The rat H-3 receptor: Gene organization and multiple isoforms, BIOC BIOP R, 280(1), 2001, pp. 75-80
Authors:
Krebs, MO
Guillin, O
Bourdel, MC
Schwartz, JC
Olie, JP
Poirier, MF
Sokoloff, P
Citation: Mo. Krebs et al., Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia, MOL PSYCHI, 5(5), 2000, pp. 558-562
Authors:
Lammers, CH
Diaz, J
Schwartz, JC
Sokoloff, P
Citation: Ch. Lammers et al., Selective increase of dopamine D-3 receptor gene expression as a common effect of chronic antidepressant treatments, MOL PSYCHI, 5(4), 2000, pp. 378-388
Authors:
Ito, C
Morisset, S
Krebs, MO
Olie, JP
Loo, H
Poirier, MF
Lannfelt, L
Schwartz, JC
Arrang, JM
Citation: C. Ito et al., Histamine H-2 receptor gene variants: lack of association with schizophrenia, MOL PSYCHI, 5(2), 2000, pp. 159-164
Authors:
Sasse, A
Stark, H
Ligneau, X
Elz, S
Reidemeister, S
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: A. Sasse et al., (Partial) agonist/antagonist properties of novel diarylalkyl carbamates onhistamine H-3 receptors, BIO MED CH, 8(5), 2000, pp. 1139-1149
Authors:
Stark, H
Ligneau, X
Sadek, B
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H-3-receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2379-2382
Authors:
Tardivel-Lacombe, J
Rouleau, A
Heron, A
Morisset, S
Pillot, C
Cochois, V
Schwartz, JC
Arrang, JM
Citation: J. Tardivel-lacombe et al., Cloning and cerebral expression of the guinea pig histamine H-3 receptor: evidence for two isoforms, NEUROREPORT, 11(4), 2000, pp. 755-759
Authors:
Arrang, JM
Schwartz, JC
Citation: Jm. Arrang et Jc. Schwartz, Untitled - Reply, NEUROREPORT, 11(12), 2000, pp. L4-L4
Authors:
Perachon, S
Betancur, C
Pilon, C
Rostene, W
Schwartz, JC
Sokoloff, P
Citation: S. Perachon et al., Role of dopamine D-3 receptors in thermoregulation: a reappraisal, NEUROREPORT, 11(1), 2000, pp. 221-225
Authors:
Bordet, R
Ridray, S
Schwartz, JC
Sokoloff, P
Citation: R. Bordet et al., Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats, EUR J NEURO, 12(6), 2000, pp. 2117-2123
Authors:
Drutel, G
Kathmann, M
Heron, A
Gros, C
Mace, S
Schwartz, JC
Arrang, JM
Citation: G. Drutel et al., Two splice variants of the hypoxia-inducible factor HIF-1 alpha as potential dimerization partners of ARNT2 in neurons, EUR J NEURO, 12(10), 2000, pp. 3701-3708
Authors:
Le Foll, B
Schwartz, JC
Sokoloff, P
Citation: B. Le Foll et al., Dopamine D-3 receptor agents as potential new medications for drug addiction, EUR PSYCHIA, 15(2), 2000, pp. 140-146
Authors:
Schwartz, JC
Citation: Jc. Schwartz, Racecadotril: a new approach to the treatment of diarrhoea, INT J ANT A, 14(1), 2000, pp. 75-79
Authors:
Diaz, J
Pilon, C
Le Foll, B
Gros, C
Triller, A
Schwartz, JC
Sokoloff, P
Citation: J. Diaz et al., Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons, J NEUROSC, 20(23), 2000, pp. 8677-8684